JME
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Journal of Molecular Endocrinology (1996) 17 89-100    DOI: 10.1677/jme.0.0170089
© 1996 Society for Endocrinology

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (48)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Florio, T
Right arrow Articles by Schettini, G
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Florio, T
Right arrow Articles by Schettini, G

Multiple intracellular effectors modulate physiological functions of the cloned somatostatin receptors

T Florio and G Schettini

Introduction: Somatostatin is a peptide widely distributed in both the central nervous system (CNS) and peripheral tissues. It is found as two bioactive peptides of 14 and 28 amino acids, the latter being an N-terminal-extended form (Reichlin 1983a).

The name somatostatin comes from its initial discovery as an inhibitor of growth hormone (GH) release from anterior pituitary cells (Brazeau et al. 1973). Since then, numerous other physiological activities of somatostatin have been discovered associated with differing peptide and receptor localization (Reichlin 1983a,b). Besides GH, somatostatin is also able to inhibit secretion of prolactin (PRL) and thyroid-stimulating hormone (TSH) (Reichlin 1983a). In the CNS, the highest somatostatin concentrations have been detected in the hypothalamus in the tuberoinfundibular neurons where, acting as a neurohormone, the peptide regulates the hypothalamic-hypophyseal axis (Schettini 1991). Somatostatin-containing neurons are also present in many other areas of the brain, such as the cerebral cortex,




This article has been cited by other articles:


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
F. Barbieri, A. Pattarozzi, M. Gatti, C. Aiello, A. Quintero, G. Lunardi, A. Bajetto, A. Ferrari, M. D. Culler, and T. Florio
Differential efficacy of SSTR1, -2, and -5 agonists in the inhibition of C6 glioma growth in nude mice
Am J Physiol Endocrinol Metab, November 1, 2009; 297(5): E1078 - E1088.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
F. P. Leu, M. Nandi, and C. Niu
The Effect of Transforming Growth Factor {beta} on Human Neuroendocrine Tumor BON Cell Proliferation and Differentiation Is Mediated through Somatostatin Signaling
Mol. Cancer Res., June 1, 2008; 6(6): 1029 - 1042.
[Abstract] [Full Text] [PDF]


Home page
J Mol EndocrinolHome page
F. Barbieri, A. Bajetto, C. Porcile, A. Pattarozzi, G. Schettini, and T. Florio
Role of stromal cell-derived factor 1 (SDF1/CXCL12) in regulating anterior pituitary function
J. Mol. Endocrinol., March 1, 2007; 38(3): 383 - 389.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
C. Hernandez, E. Carrasco, R. Casamitjana, R. Deulofeu, J. Garcia-Arumi, and R. Simo
Somatostatin Molecular Variants in the Vitreous Fluid: A comparative study between diabetic patients with proliferative diabetic retinopathy and nondiabetic control subjects
Diabetes Care, August 1, 2005; 28(8): 1941 - 1947.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
S. Arena, A. Pattarozzi, A. Corsaro, G. Schettini, and T. Florio
Somatostatin Receptor Subtype-Dependent Regulation of Nitric Oxide Release: Involvement of Different Intracellular Pathways
Mol. Endocrinol., January 1, 2005; 19(1): 255 - 267.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Massa, F. Barbieri, C. Aiello, S. Arena, A. Pattarozzi, P. Pirani, A. Corsaro, R. Iuliano, A. Fusco, G. Zona, et al.
The Expression of the Phosphotyrosine Phosphatase DEP-1/PTP{eta} Dictates the Responsivity of Glioma Cells to Somatostatin Inhibition of Cell Proliferation
J. Biol. Chem., July 9, 2004; 279(28): 29004 - 29012.
[Abstract] [Full Text] [PDF]


Home page
J. Histochem. Cytochem.Home page
E. Ludvigsen, R. Olsson, M. Stridsberg, E. T. Janson, and S. Sandler
Expression and Distribution of Somatostatin Receptor Subtypes in the Pancreatic Islets of Mice and Rats
J. Histochem. Cytochem., March 1, 2004; 52(3): 391 - 400.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
T. Florio, M. Morini, V. Villa, S. Arena, A. Corsaro, S. Thellung, M. D. Culler, U. Pfeffer, D. M. Noonan, G. Schettini, et al.
Somatostatin Inhibits Tumor Angiogenesis and Growth via Somatostatin Receptor-3-Mediated Regulation of Endothelial Nitric Oxide Synthase and Mitogen-Activated Protein Kinase Activities
Endocrinology, April 1, 2003; 144(4): 1574 - 1584.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
S. B. Curtis, J. Hewitt, S. Yakubovitz, A. Anzarut, Y. N. Hsiang, and A. M. J. Buchan
Somatostatin receptor subtype expression and function in human vascular tissue
Am J Physiol Heart Circ Physiol, June 1, 2000; 278(6): H1815 - H1822.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
A. ALBINI, T. FLORIO, D. GIUNCIUGLIO, L. MASIELLO, S. CARLONE, A. CORSARO, S. THELLUNG, T. CAI, D. M. NOONAN, and G. SCHETTINI
Somatostatin controls Kaposi's sarcoma tumor growth through inhibition of angiogenesis
FASEB J, April 1, 1999; 13(6): 647 - 655.
[Abstract] [Full Text]


Home page
EndocrinologyHome page
T. Florio, A. Scorziello, S. Thellung, S. Salzano, M. T. Berlingieri, A. Fusco, and G. Schettini
Oncogene Transformation of PC Cl3 Clonal Thyroid Cell Line Induces an Autonomous Pattern of Proliferation That Correlates with a Loss of Basal and Stimulated Phosphotyrosine Phosphatase Activity
Endocrinology, September 1, 1997; 138(9): 3756 - 3763.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1996 by the Society for Endocrinology.